+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
All Ages
All Genders
ID07604402

Evaluating Safety of Transcatheter Aortic Valve Implantation Without On-site Cardiac Surgery A Randomized Study Comparing Outcomes in Centers With and Without On-site Cardiac Surgery

Led by University Hospital of Ferrara · Updated on 2026-08-21

1612

Participants Needed

11

Research Sites

208 weeks

Total Duration

AI-Summary

What This Trial Is About

The trial investigates whether transcatheter aortic valve implantation TAVI can be safely and effectively performed in hospitals without on-site cardiac surgery for patients with severe symptomatic aortic stenosis. This multicenter, randomized study compares outcomes between centers with and without on-site cardiac surgery to determine if patient safety is maintained when appropriate selection, experienced operators, advanced imaging, and transfer plans are in place. The goal is to improve access to timely treatment while ensuring clinical safety at 1 year. Participants will be randomly assigned to receive TAVI either in a center without on-site cardiac surgery or in a center with on-site cardiac surgery. Both groups undergo the procedure performed by experienced operators following current guidelines and standards. Centers without on-site surgery must have advanced imaging, procedural expertise, and established transfer pathways. Patients will be evaluated beforehand with clinical, echocardiographic, laboratory, coronary, and computed tomography assessments to confirm eligibility and procedural feasibility. During the study, participants will be monitored for clinical outcomes including death from any cause, stroke, and hospitalizations related to the procedure or implanted valve at 1 year. Safety events such as valve-related death and major complications will also be recorded. Clinical events will be reviewed by an independent committee blinded to treatment assignment, and patient safety will be overseen by a data monitoring board. After hospital discharge, participants will have structured follow-up visits to assess health status, adverse events, and hospitalizations, with total participation lasting up to 1 year.

CONDITIONS

Brief Title

TRanscatheter Aortic-Valve Implantation Without On-site Cardiac Surgery

Research Team

G

Gianluca Campo, MD

A

Alice Santoni

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here